Arteris, Inc. (NASDAQ:AIP) Shares Bought by State Street Corp

State Street Corp lifted its position in shares of Arteris, Inc. (NASDAQ:AIP) by 18.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 410,578 shares of the company’s stock after acquiring an additional 64,081 shares during the quarter. State Street Corp owned 1.02% of Arteris worth $3,170,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. US Bancorp DE acquired a new position in shares of Arteris during the 3rd quarter worth approximately $34,000. The Manufacturers Life Insurance Company acquired a new position in Arteris during the second quarter worth $86,000. Algert Global LLC purchased a new position in Arteris during the second quarter valued at $115,000. MetLife Investment Management LLC grew its position in shares of Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris during the third quarter worth about $226,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Trading Up 0.8 %

Shares of AIP stock opened at $10.35 on Tuesday. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $10.69. The stock has a market cap of $415.83 million, a price-to-earnings ratio of -10.78 and a beta of 1.25. The company’s 50-day moving average price is $8.56 and its 200-day moving average price is $7.97. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.

Insider Transactions at Arteris

In other Arteris news, Director Isabelle F. Geday sold 15,550 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total transaction of $140,416.50. Following the transaction, the director now directly owns 121,213 shares in the company, valued at $1,094,553.39. This represents a 11.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Saiyed Atiq Raza sold 12,166 shares of Arteris stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $10.07, for a total value of $122,511.62. Following the completion of the sale, the director now directly owns 731,560 shares of the company’s stock, valued at $7,366,809.20. The trade was a 1.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 216,086 shares of company stock worth $2,080,080 in the last 90 days. Insiders own 33.70% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.